Sebelipase Alfa

ATC A16AB14 · 6 markets · 7 records

Sebelipase Alfa 6 markets · 7 records Forms

AU 2 records · 2 strengths

  • 2 mg/mLinjectionKANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial also in SG unknown

Records without a stated strength · 1 KANUMA

GB 1 records · 1 strengths

  • 20 mg/10 mLinjectionKanuma 20mg/10ml concentrate for solution for infusion vials

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 2 mg/mLinjectionKANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML also in AU

HK 1 records · 1 strengths

    Records without a stated strength · 1 KANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 KANUMA

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.